Skip to main content

previous disabled Page of 202
and
  1. Article

    Open Access

    Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study

    This study aimed to compare the survival outcome and side effects in patients with primary high-grade glioma (HGG) who received carbon ion radiotherapy (CIRT) alone or as a boost strategy after photon radiatio...

    **aoJun Li, YanShan Zhang, YanCheng Ye, SuQing Tian, TingChao Hu, HongYu Chai in BMC Cancer (2024)

  2. Article

    Open Access

    Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study

    This study aimed to investigate the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for primary prophylaxis of neutropenia in patients with cervical cance...

    **g You, Yidi Yuan, **aoxuan Gu, Weihu Wang, **aofan Li in BMC Cancer (2024)

  3. Article

    Open Access

    Nomogram for predicting the probability of rectal anastomotic re-leakage after stoma closure: a retrospective study

    In this study, we aimed to identify the risk factors in patients with rectal anastomotic re-leakage and develop a prediction model to predict the probability of rectal anastomotic re-leakage after stoma closure.

    Yuegang Li, Gang Hu, **zhu Zhang, Wenlong Qiu, Shiwen Mei, **shan Wang in BMC Cancer (2024)

  4. Article

    Open Access

    An analysis of the role of GAB2 in pan-cancer from a multidimensional perspective

    To explore the role of GAB2 in pan-cancer based on bioinformatics analysis.

    Yi Yin, Yong Li, Yaoyang Zhang, Qiucheng Jia, Huiming Tang in Discover Oncology (2024)

  5. Article

    Open Access

    eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

    Extracellular heat shock protein 90 AA1(eHSP90α) is intricately linked to tumor progression and prognosis. This study aimed to investigate the difference in the value of eHSP90α in post-treatment response asse...

    Yingzhen Bian, Haizhou Liu, **glei Huang, Zhaorong Feng, Yanyan Lin in BMC Cancer (2024)

  6. Article

    Open Access

    Correction: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy

    Yu-An Li, Chuan Zhao, **g-**g Ge, Cheng Li, Feng-Jun Xue, Shao-Pei Qi in BMC Cancer (2024)

  7. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai in BMC Cancer (2024)

  8. Article

    Open Access

    Novel associations between MTDH gene polymorphisms and invasive ductal breast cancer: a case–control study

    To reveal the contributing effects of MTDH gene SNPs in the risk of invasive ductal breast cancer (IDC).

    Yan Huang, Dan Dai, Li Zhu, **anzhong Qi in Discover Oncology (2024)

  9. Article

    Open Access

    Investigation of prognostic values of immune infiltration and LGMN expression in the microenvironment of osteosarcoma

    Osteosarcoma (OS), the most common primary malignant bone tumor, predominantly affects children and young adults and is characterized by high invasiveness and poor prognosis. Despite therapeutic advancements, ...

    Hualiang Xu, Dawei Xu, Yinfeng Zheng, Huajun Wang, Aiguo Li in Discover Oncology (2024)

  10. Article

    Open Access

    Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study

    To develop and authenticate a neoadjuvant chemotherapy (NACT) pathological complete remission (pCR) model based on the expression of Reg IV within breast cancer tissues with the objective to provide clinical g...

    Jiao-fei Wei, Fan Li, Jia-wen Lin, Zi-ang Dou, Shu-qin Li, Jun Shen in Breast Cancer (2024)

  11. No Access

    Article

    Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis

    Breast-conserving surgery (BCS) plus radiotherapy and mastectomy exhibit highly comparable prognoses for early-stage breast cancer; however, the safety of BCS for T1-2N3M0 breast cancer remains unclear. This s...

    Yunbo Luo, **aomei Chen, Ruibo Lv, Qingyun Li, Shuangqiang Qian, **a Xu in Breast Cancer (2024)

  12. Article

    Open Access

    Selective anti-tumor activity of glutathione-responsive abasic site trap** agent in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive thyroid cancer with poor prognosis. Killing cancer cells by inducing DNA damage or blockage of DNA repair is a promising strategy for chemothe...

    **yan Chai, Mengxue Su, Ruiguo Zhang, Ning Li, Yuanyuan Jia, Wei Zheng in BMC Cancer (2024)

  13. Article

    Open Access

    Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis

    Non-small cell lung cancer (NSCLC) is the primary reason for cancer-related deaths globally. Tertiary lymphoid structure (TLS) is an organized collection of immune cells acquired in non-physiological, non-lymp...

    Luyuan Ma, Rongyang Li, **aomeng Liu, Wenhao Yu, Zhanpeng Tang, Yi Shen in BMC Cancer (2024)

  14. Article

    Open Access

    KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer

    There is mounting evidence that patients with liver cancer can benefit from Immune checkpoint inhibitors. However, due to the high cost and low efficacy, we aimed to explore new biomarkers for predicting the e...

    Sihui Zhu, Yuncheng **, Mingzhen Zhou, Lin Li, Xueru Song, **nyu Su in BMC Cancer (2024)

  15. Article

    Open Access

    Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1

    Drug resistance remains a significant challenge in the treatment of pancreatic cancer. The development of drug-resistant cell lines is crucial to understanding the underlying mechanisms of resistance and devel...

    Cheng Yu, Yuanhui Su, **n Miao, Changpeng Chai, Huan Tang, Lu Li, Jianfeng Yi in BMC Cancer (2024)

  16. Article

    Open Access

    Establishment of a nomogram to predict the overall survival of patients with collecting duct renal cell carcinoma

    Collecting duct carcinoma (CDC) is a rare histological type of renal cell carcinoma that lacks a prognostic prediction model. In this study, we developed a nomogram to predict the prognosis of CDC patients.

    Weixing Jiang, Zuowei Zou, Li Wen in Discover Oncology (2024)

  17. No Access

    Article

    Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies

    Antibody–drug conjugates (ADCs) represent a crucial component of targeted therapies in gastric cancer, potentially altering traditional treatment paradigms. Many ADCs have entered rigorous clinical trials base...

    Jia-Lin Hao, **n-Yun Li, Yu-Tong Liu, Ji-Xuan Lang, Di-Jie Liu in Gastric Cancer (2024)

  18. Article

    Open Access

    PANoptosis-based molecular subtype and prognostic model predict survival and immune landscape in esophageal cancer

    To establish a prognostic model to predict the survival of patients with esophageal cancer (EC).

    Zheming Liu, Jiahui Liu, Fuben Liao, Wei Li, **g Wang in Clinical Cancer Bulletin (2024)

  19. Article

    Open Access

    Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients

    Gene expression profiles in breast tissue biopsies contain information related to chemotherapy efficacy. The promoter profiles in cell-free DNA (cfDNA) carrying gene expression information of the original tiss...

    Xu Yang, Qing Liu, Zhiwei Guo, Xuexi Yang, Kun Li, Bowei Han in Breast Cancer Research (2024)

  20. Article

    Open Access

    Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

    Endocrine therapy is the most important treatment modality of breast cancer patients whose tumors express the estrogen receptor α (ERα). The androgen receptor (AR) is also expressed in the vast majority (80–90...

    Huanyao Gao, Lixuan Wei, Shreya Indulkar, Thanh Thanh. L. Nguyen in Breast Cancer Research (2024)

previous disabled Page of 202